Join Us in Advancing Alzheimer’s Research—Your Blood Sample Can Make a Difference
Tatiana Foroud
Primary Investigator
Brief description of study
One Blood Sample. One Visit. A Big Impact.
The Indiana Biobank is a research program that began in 2010 through the Indiana University School of Medicine and IU Health. You can think of it like a huge library—only instead of storing books, it stores more than 60,000 blood and other medical samples.
Each sample is linked to a person’s medical records, but names and personal details are removed before researchers ever see them. This protects privacy while still allowing doctors and scientists to learn from the information.
This particular study is part of the Biobank’s special collections for Alzheimer’s research.. It focuses on gathering blood samples from three groups of people:
- Individuals with Alzheimer’s disease (AD),
- Individuals with cognitive impairment, and
- Healthy adults (known as “controls”)
By studying these samples, scientists can make sure that Alzheimer’s-related blood tests give consistent, reliable results no matter which lab looks at them. This is an important step toward improving how we diagnose and understand Alzheimer’s disease.
More information about the Indiana Biobank, as well as FAQs, can be found here: https://iuhealth.org/find-medical-services/indiana-biobank
Detailed description of study
If you choose to participate:
- You will be asked to give one small blood sample during a single study visit at the IU Health Neuroscience Center (Goodman Hall) on the IU Indianapolis campus.
- Your sample will join our collection of information at the Indiana Biobank from more than 60,000 other volunteers. These samples are used in many types of research. Because your sample is unique, it can play an important role in helping doctors develop treatments that work well for all kinds of people in the future.
- As a thank you for your time, you will receive a $25 Amazon e-gift card, and we will also cover your parking for the visit.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Healthy, Alzheimer's Disease, Dementia, Cognitive Impairment, MCI, SCI
-
Age: 50 years or above
-
Gender: All
Cohort A - AD/Dementia:
- Any diagnosis of dementia (AD, Lewy Body, PD, etc)
- Not on a clinical trial/taking investigational products
- Not taking amyloid clearing medications
Cohort B - Cognitive Impairment:
- Assessed for/History of cognitive impairment (or diagnosis of SCI or MCI)
- No diagnosis dementia
- Not taking amyloid clearing medications
Cohort C - Healthy Controls:
- No report of dementia
- Not on a clinical trial/taking investigational products
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
